The model-adjusted treatment difference of @ % ( @ % CI -@ % , @ % ) ( @ mmol/mol -LSB- @ % CI -@ , @ mmol/mol -RSB- ) indicated non-inferiority of albiglutide to insulin glargine based on the pre-specified non-inferiority margin of @ % ( @ mmol/mol , p = @ ) .